peptide (PGC, intravenous, liver cirrhosis) (PharmaIN)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepeptide (PGC, intravenous, liver cirrhosis) (PharmaIN)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Cirrhosis +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaIN Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaIN Corp
Active IndicationsN/A
Inactive IndicationsLiver Cirrhosis +[2] 

Other Information

ATC CodeN/A
Related LinksN/A